Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series

被引：0
|
作者：
Luigi Francesco Iannone
Davide Fattori
Pierangelo Geppetti
Francesco De Cesaris
机构：
[1] Careggi University Hospital,Headache Center and Clinical Pharmacology Unit
[2] University of Florence,Section of Clinical Pharmacology and Oncology, Department of Health Sciences
来源：
Neurological Sciences | 2022年 / 43卷
关键词：
Calcitonin gene-related peptide; Cluster headache; Migraine; Galcanezumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：697 / 703
页数：6
相关论文
共 50 条
  • [1] Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series
    Iannone, Luigi Francesco
    Fattori, Davide
    Geppetti, Pierangelo
    De Cesaris, Francesco
    NEUROLOGICAL SCIENCES, 2022, 43 (01) : 697 - 703
  • [2] Cervicogenic Headache Responsive to Galcanezumab in Patients With Comorbid Migraine: A Case Series
    Mehta, D.
    Watson, J.
    Kissoon, N.
    HEADACHE, 2020, 60 : 7 - 7
  • [3] Galcanezumab for episodic and chronic cluster headache
    Pohl, Heiko
    Holle-Lee, Dagny
    Broicher, Sarah D.
    Schwerdtner, Inka
    Gantenbein, Andreas R.
    Gaul, Charly
    SCHMERZ, 2023, 37 (03): : 168 - 174
  • [4] Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases
    Kashiwagi, Kenta
    Katsuki, Masahito
    Kawamura, Shin
    Tachikawa, Senju
    Ono, Atsuko
    Koh, Akihito
    NEUROLOGY INTERNATIONAL, 2023, 15 (01): : 318 - 324
  • [5] Erenumab Efficacy on Comorbid Cluster Headache in Patients With Migraine: A Real-World Case Series
    Silvestro, Marcello
    Tessitore, Alessandro
    Scotto di Clemente, Fabrizio
    Tedeschi, Gioacchino
    Russo, Antonio
    HEADACHE, 2020, 60 (06): : 1187 - 1195
  • [6] Galcanezumab add-on in refractory cluster headache. A case series
    Karagiorgis, Georgios
    Christofilos, Savvas
    Deligianni, Christina
    Spanou, Ioanna
    Vassilopoulou, Sofia
    Mitsikostas, Dimos-Dimitrios D.
    PAIN MANAGEMENT, 2024, 14 (09) : 491 - 495
  • [7] Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review
    Membrilla, Javier A.
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Caronna, Edoardo
    Pozo-Rosich, Patricia
    HEADACHE, 2022, 62 (10): : 1395 - 1405
  • [8] Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache
    Ossipov, M. H.
    Raffa, R. B.
    Pergolizzi, J. V., Jr.
    DRUGS OF TODAY, 2020, 56 (01) : 5 - 19
  • [9] Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache
    Lesley J. Scott
    Drugs, 2020, 80 : 893 - 904
  • [10] Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache
    Scott, Lesley J.
    DRUGS, 2020, 80 (09) : 893 - 904
12345